Aldh-2 inhibitors in the treatment of addiction

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 311/36 (2006.01) A61K 31/353 (2006.01) A61P 25/32 (2006.01) C07D 405/04 (2006.01) C07D 405/14 (2006.01) C07D 413/12 (2006.01) C07D 413/14 (2006.01) C07D 417/12 (2006.01)

Patent

CA 2712750

Disclosed are novel isoflavone derivatives having the structure of Formula I which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example addiction to dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and alcohol.

La présente invention concerne de nouveaux dérivés d'isoflavone, dont la structure est représentée par la formule (I), qui se révèlent utiles en tant qu'inhibiteurs d'ALDH-2 pour traiter des mammifères qui dépendent de substances créant un effet d'accoutumance, par exemple l'accoutumance à un agent produisant de la dopamine tel que la cocaïne, la morphine, les amphétamines, la nicotine et l'alcool.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Aldh-2 inhibitors in the treatment of addiction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aldh-2 inhibitors in the treatment of addiction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aldh-2 inhibitors in the treatment of addiction will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2011931

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.